1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2021 - Europe

Pathology Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Pharma Intelligence
1-30 of about 100 reports

Point of Care Diagnostics

  • $ 4750
  • June 2021
  • 121 pages

Overview Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. ...

  • World
  • Spain
  • In Vitro Diagnostics
  • Point Of Care Testing
  • Industry analysis

Company Analysis: Shionogi

  • $ 3000
  • January 2021
  • 40 pages

PharmaVitae explores Shionogi’s prescription pharmaceutical performance and outlook through to 2029. Snapshot Overview – PharmaVitae forecasts Shionogi’s revenue to remain flat through 2029, ...

  • Japan
  • United States
  • Prescription Drug
  • Influenza
  • Company research
  • Company

Company Analysis: Astellas

  • $ 3000
  • January 2021
  • 45 pages

PharmaVitae explores Astellas’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Astellas is forecast to grow revenue until 2026, at which point flagship ...

  • United States
  • Europe
  • Prostate Cancer
  • Company research
  • Company

Company Analysis: Gilead

  • $ 3000
  • January 2021
  • 67 pages

PharmaVitae explores Gilead’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Gilead’s sales will remain broadly stable over the medium term due to its ...

  • United States
  • Europe
  • Prescription Drug
  • Autoimmune Disease
  • Company research
  • Company

Company Analysis: UCB

  • $ 3000
  • January 2021
  • 38 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Johnson & Johnson Company Analysis, Pharma Intelligence

  • $ 3000
  • July 2020
  • 62 pages

PharmaVitae explores Johnson and Johnson’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Johnson and Johnson’s growth will be driven by its pharmaceuticals ...

  • United States
  • Europe
  • Pharmaceutical
  • Leukemia
  • Company research
  • Company

UCB Company Analysis

  • $ 3000
  • July 2020
  • 43 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI products ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Biogen

  • $ 3000
  • July 2020
  • 41 pages

PharmaVitae explores Biogen’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Biogen’s prescription pharmaceutical business will see stable performance ...

  • United States
  • European Union
  • Prescription Drug
  • Neurological Disorder
  • Industry analysis

Alexion

  • $ 3000
  • July 2020
  • 43 pages

PharmaVitae explores Alexion’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Alexion’s rare diseases portfolio maintains its solid growth and attractive ...

  • Europe
  • Japan
  • Infectious Disease
  • Neurology
  • Industry analysis

2019 Biomedtracker / Datamonitor Healthcare Post-ESMO Report

  • $ 4750
  • October 2019
  • 117 pages

The Annual European Society for Medical Oncology (ESMO) 2019 Congress was held in Barcelona, Spain from September 27 to October 1, 2019. Conference highlights included new data from PARP inhibitors in ...

  • Spain
  • Catalonia
  • Breast Cancer
  • Targeted Therapy
  • Industry analysis

Drug Delivery: Inhalation Devices

  • $ 4750
  • October 2019
  • 47 pages

Overview In 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

  • World
  • Spain
  • Asthma
  • Drug Delivery
  • Industry analysis
  • Asthma Prevalence

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

  • $ 3000
  • November 2018
  • 80 pages

Payers are concerned about the budget impact of immunotherapies As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, interviewed payers express concern surrounding ...

  • Europe
  • Hepatitis
  • Immunotherapy
  • Industry analysis

Market Spotlight: Systemic Lupus Erythematosus (SLE)

  • $ 1318
  • May 2021
  • 40 pages

This Market Spotlight report covers the Systemic Lupus Erythematosus (SLE) market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory ...

  • World
  • Europe
  • Clinical Trial
  • Musculoskeletal Disorder
  • Industry analysis
  • Drug Approval

Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL), Pharma Intelligence

  • $ 1318
  • May 2021
  • 45 pages

This Market Spotlight report covers the Cutaneous T-Cell Lymphoma (CTCL) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, ...

  • World
  • Europe
  • Clinical Trial
  • Lymphoma
  • Industry analysis

Market Spotlight: Eating Disorders, Pharma Intelligence

  • $ 1318
  • April 2021
  • 32 pages

This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, a 10-year disease ...

  • World
  • Europe
  • Eating Disorder
  • Industry analysis
  • Drug Approval

Market Spotlight: Uterine Cancer, Pharma Intelligence

  • $ 1318
  • April 2021
  • 42 pages

This Market Spotlight report covers the Uterine Cancer market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • World
  • Europe
  • Cancer
  • Clinical Trial
  • Industry analysis
  • Drug Approval

Market Spotlight: Fibromyalgia

  • $ 1318
  • March 2021
  • 37 pages

This Market Spotlight report covers the Fibromyalgia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • World
  • Europe
  • Chronic Pain
  • Clinical Trial
  • Industry analysis
  • Drug Approval

Market Spotlight: Basal Cell Carcinoma, Pharma Intelligence

  • $ 1318
  • March 2021
  • 35 pages

This Market Spotlight report covers the Basal Cell Carcinoma market, comprising key marketed and pipeline drugs, epidemiology, recent events and analyst opinion, clinical trials, upcoming and regulatory ...

  • World
  • Europe
  • Cancer
  • Industry analysis
  • Drug Approval

Market Spotlight: Zika virus, Pharma Intelligence

  • $ 1318
  • February 2021
  • 24 pages

This Market Spotlight report covers the Zika virus market, comprising key pipeline therapies, clinical trials, probability of success, epidemiology, and licensing and acquisition deals. Key Takeaways The ...

  • World
  • South America
  • Infectious Disease
  • Industry analysis

Market Spotlight: Hidradenitis Suppurativa, Pharma Intelligence

  • $ 1318
  • February 2021
  • 33 pages

This Market Spotlight report covers the Hidradenitis Suppurativa market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of ...

  • World
  • Europe
  • Clinical Trial
  • Autoimmune Disease
  • Industry analysis
  • Drug Approval

Market Spotlight: Hepatitis B

  • $ 1318
  • February 2021
  • 55 pages

This Market Spotlight report covers the Hepatitis B market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events, probability of success, ...

  • World
  • Europe
  • Hepatitis
  • Clinical Trial
  • Industry analysis
  • Infectious Disease Prevalence

Market Spotlight: Obesity

  • $ 1318
  • February 2021
  • 52 pages

This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming and regulatory events, probability of ...

  • World
  • Asia
  • Obesity
  • Clinical Trial
  • Industry analysis
  • Drug Approval

Market Spotlight: Glaucoma, Pharma Intelligence

  • $ 1318
  • February 2021
  • 47 pages

Overview This Market Spotlight report covers the Glaucoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, probability of success, recent events and ...

  • World
  • Europe
  • Ophthalmology
  • Eye Disease
  • Industry analysis
  • Drug Approval

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS), Pharma Intelligence

  • $ 1318
  • February 2021
  • 44 pages

Amyotrophic lateral sclerosis (ALS) is a fatal late-onset neurodegenerative disorder characterized by progressive muscular paralysis. It leads to damage of the upper and lower motor neurons present in ...

  • World
  • Europe
  • Dementia
  • Industry analysis

HR+/HER2- Breast Cancer Pricing, Reimbursement, and Access

  • $ 2995
  • October 2018
  • 85 pages

Spend on breast cancer medicines is a high-level concern for payers, but few access restrictions are in place Despite a high level of concern regarding spend on breast cancer medicines, access restrictions ...

  • Europe
  • Spain
  • Breast Cancer
  • Industry analysis

Market Spotlight: Psoriatic Arthritis

  • $ 1318
  • September 2020
  • 65 pages

This Market Spotlight report covers the psoriatic arthritis market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory events, probability ...

  • World
  • Europe
  • Autoimmune Disease
  • Industry analysis
  • Drug Approval

Market Spotlight: Atopic Dermatitis

  • $ 1318
  • August 2020
  • 81 pages

Overview Atopic dermatitis (AD), also known as atopic eczema, is a chronic, pruritic, relapsing inflammatory dermatological condition. The condition usually begins during early infancy and childhood, ...

  • World
  • Europe
  • Dermatological Condition
  • Industry analysis
  • Drug Approval

Bladder Cancer Pricing, Reimbursement, and Access

  • $ 2995
  • September 2018
  • 79 pages

Overview Payers are concerned about the budget impact of immunotherapies in oncology as a whole, rather than bladder cancer as an indication Payers are likely to enter preferential contracts/tenders with ...

  • Europe
  • Bladder Cancer
  • Industry analysis

Shire Company Analysis, Pharma Intelligence

  • $ 3000
  • August 2018
  • 64 pages

PharmaVitae explores Shire’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product ...

  • Europe
  • United States
  • Prescription Drug
  • Blood Disease
  • Company research
  • Company

Renal Cell Cancer Pricing, Reimbursement, and Access

  • $ 2995
  • August 2018
  • 91 pages

Overview There is moderate concern among payers regarding spend on renal cell cancer (RCC) drugs, but access restrictions remain mild. Spend in RCC is among the top five oncology indications. Although ...

  • Europe
  • United States
  • Renal Cancer
  • Clinical Trial
  • Industry analysis
About 33000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Infectious Disease Demographic Impact in Wales (UK) and England (UK)

  • October 2021
  • 19 pages
  • England
  • Wales
  • Pathology
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Cause-Specific Mortality Rate

EU Economic Analysis October 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on